Welcome

to the homepage of the Clinical Division of General Psychiatry at the Medical University of Vienna’s Department of Psychiatry and Psychotherapy

This website provides an overview on the

  • Patient care
  • Science and research
  • Study and teaching


that we offer, as well as general information on our division.

For questions or comments please contact us at:
gen-psychiatry@meduniwien.ac.at


Univ.Prof.Dr.Dan RUJESCU

Head of the Division of General Psychiatry

Ao.Univ.Prof. Dr.med. Richard Frey
Deputy division head

News

 
   

3. Platz für Dr. Sebastian Klug

 
 

Pia Baldinger-Melich und Benjamin Spurny-Dworak unter den Ausgezeichneten

 
 

(1.7.2022) Rupert Lanzenberger hält die Antrittsvorlesung für seine Professur in Klinischen Neurowissenschaften im Van Swieten Festsaal zum Thema „GEHIRN EINBLICKE: Über die molekulare und funktionelle Bildgebung in der Psychiatrie“. Anschließend..

 
 

(28.04.2022) Für herausragende medizinische Forschungsleistungen junger WissenschafterInnen wird der Johann Wilhelm Ritter von Mannagetta-Förderpreis für Medizin von der Österreichischen Akademie der Wissenschaften (ÖAW) einmal im Jahr vergeben...

 
 

(12.04.2022) In the largest study so far conducted into schizophrenia, which included more than 320,000 participants, scientists from the Psychiatric Genomics Consortium (PGC), a group of several hundred researchers from 45 countries, identified a..

 
 

Alexander Kautzky (1st) and Jakob Unterholzner (3rd) are the recipients

 
 

(12.10.2021) The Division of General Psychiatry also uses its Twitter account for information on psychiatry research, training and other news - follow us at: @PsychVienna  

 
 

08.09.2021) On 1 September, Rupert Lanzenberger, a neuroscientist specialising in molecular and functional imaging in psychiatry at the Medical University of Vienna, took up a § 99(4) professorship in the subject field Clinical Neurosciences at..

 
 

Rupert Lanzenberger and Gregor Gryglewski are among the honoured researchers

 
 

Selective serotonin reuptake inhibitors (SSRIs) increase neuroplasticity